Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Apr;81(4):976–981. doi: 10.1172/JCI113451

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver.

J F Caro 1, J Poulos 1, O Ittoop 1, W J Pories 1, E G Flickinger 1, M K Sinha 1
PMCID: PMC329620  PMID: 2832449

Abstract

Insulin-like growth factor-I (IGF-I) in human hepatoma cells (HEP-G2) has, in addition to its effect on cell growth, short-term metabolic effects acting through its own receptor. We have demonstrated that normal human hepatocytes, compared with HEP-G2 cells, have virtually no IGF-I binding sites. Because the rate of growth is the major difference between the hepatoma and the normal liver, we asked if normal liver might express IGF-I binding sites under physiologic growth conditions. Indeed, whereas adult rat hepatocytes have low IGF-I binding sites similar to those in human liver, hepatocytes from regenerating liver after 3 d subtotal hepatectomy have an approximately sixfold increase (P less than 0.005) and those from fetal rat liver a approximately 12-fold increase (P less than 0.005), to levels comparable to those in the HEP-G2 cells. The specificity of 125I IGF-I binding to its receptor was demonstrated by competition studies with monoclonal antibodies directed toward the IGF-I and the insulin receptors, with unlabeled IGF-I and insulin and by affinity labeling experiments. Thus, if IGF-I has any short-term metabolic functions in the adult human liver, it is not through interaction with its own receptor. Autocrine regulation by IGF-I of liver growth appears possible since IGF-I binding sites are expressed under pathological and physiological conditions of growth. The mechanism that couples these two phenomena remains to be elucidated.

Full text

PDF
976

Images in this article

979Image
on p.979
979Image
on p.979

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baxter R. C., Turtle J. R. Stimulation of protein synthesis in isolated hepatocytes by somatomedin. Metabolism. 1978 May;27(5):503–506. doi: 10.1016/0026-0495(78)90014-8. [DOI] [PubMed] [Google Scholar]
  2. Beguinot F., Kahn C. R., Moses A. C., Smith R. J. Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells. J Biol Chem. 1985 Dec 15;260(29):15892–15898. [PubMed] [Google Scholar]
  3. Blackard W. G., Guzelian P. S., Small M. E. Down regulation of insulin receptors in primary cultures of adult rat hepatocytes in monolayer. Endocrinology. 1978 Aug;103(2):548–553. doi: 10.1210/endo-103-2-548. [DOI] [PubMed] [Google Scholar]
  4. Caro J. F., Ittoop O., Pories W. J., Meelheim D., Flickinger E. G., Thomas F., Jenquin M., Silverman J. F., Khazanie P. G., Sinha M. K. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J Clin Invest. 1986 Jul;78(1):249–258. doi: 10.1172/JCI112558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Caro J. F., Lanza-Jacoby S. Insulin resistance in uremia. Characterization of lipid metabolism in freshly isolated and primary cultures of hepatocytes from chronic uremic rats. J Clin Invest. 1983 Sep;72(3):882–892. doi: 10.1172/JCI111059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chen R. F. Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem. 1967 Jan 25;242(2):173–181. [PubMed] [Google Scholar]
  7. Chernausek S. D., Beach D. C., Banach W., Sperling M. A. Characteristics of hepatic receptors for somatomedin-C/insulin-like growth factor I and insulin in the developing human. J Clin Endocrinol Metab. 1987 Apr;64(4):737–743. doi: 10.1210/jcem-64-4-737. [DOI] [PubMed] [Google Scholar]
  8. Flier J. S., Usher P., Moses A. C. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts. Proc Natl Acad Sci U S A. 1986 Feb;83(3):664–668. doi: 10.1073/pnas.83.3.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frank H. J., Pardridge W. M., Morris W. L., Rosenfeld R. G., Choi T. B. Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes. 1986 Jun;35(6):654–661. doi: 10.2337/diab.35.6.654. [DOI] [PubMed] [Google Scholar]
  10. Freemark M., D'Ercole A. J., Handwerger S. Somatomedin-C stimulates glycogen synthesis in fetal rat hepatocytes. Endocrinology. 1985 Jun;116(6):2578–2582. doi: 10.1210/endo-116-6-2578. [DOI] [PubMed] [Google Scholar]
  11. Freemark M. Epidermal growth factor stimulates glycogen synthesis in fetal rat hepatocytes: comparison with the glycogenic effects of insulin-like growth factor I and insulin. Endocrinology. 1986 Aug;119(2):522–526. doi: 10.1210/endo-119-2-522. [DOI] [PubMed] [Google Scholar]
  12. Fryklund L., Uthne K., Sievertsson H. Indentification of two somatomedin A active polypeptides and in vivo effects of a somatomedin A concentrate. Biochem Biophys Res Commun. 1974 Dec 11;61(3):957–962. doi: 10.1016/0006-291x(74)90248-4. [DOI] [PubMed] [Google Scholar]
  13. Heaton J. H., Krett N. L., Alvarez J. M., Gelehrter T. D., Romanus J. A., Rechler M. M. Insulin regulation of insulin-like growth factor action in rat hepatoma cells. J Biol Chem. 1984 Feb 25;259(4):2396–2402. [PubMed] [Google Scholar]
  14. Hwan J. C., Freeman M. E. Partial purification of a hypothalamic factor that inhibits gonadotropin-releasing hormone-stimulated luteinizing hormone release. Endocrinology. 1987 Feb;120(2):483–490. doi: 10.1210/endo-120-2-483. [DOI] [PubMed] [Google Scholar]
  15. Izumi T., Kasuga M., Kadowaki T., Hizuka N., Takaku F., Akanuma Y. Characteristics of human erythrocyte insulin-like growth factor I receptors. J Clin Endocrinol Metab. 1986 Jun;62(6):1206–1212. doi: 10.1210/jcem-62-6-1206. [DOI] [PubMed] [Google Scholar]
  16. Kasuga M., Van Obberghen E., Nissley S. P., Rechler M. M. Demonstration of two subtypes of insulin-like growth factor receptors by affinity cross-linking. J Biol Chem. 1981 Jun 10;256(11):5305–5308. [PubMed] [Google Scholar]
  17. Knowles B. B., Howe C. C., Aden D. P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 1980 Jul 25;209(4455):497–499. doi: 10.1126/science.6248960. [DOI] [PubMed] [Google Scholar]
  18. Koch K. S., Shapiro P., Skelly H., Leffert H. L. Rat hepatocyte proliferation is stimulated by insulin-like peptides in defined medium. Biochem Biophys Res Commun. 1982 Dec 15;109(3):1054–1060. doi: 10.1016/0006-291x(82)92046-0. [DOI] [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Lee P. D., Rosenfeld R. G., Hintz R. L., Smith S. D. Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J Clin Endocrinol Metab. 1986 Jan;62(1):28–35. doi: 10.1210/jcem-62-1-28. [DOI] [PubMed] [Google Scholar]
  21. Lesko L., Donlon M., Marinetti G. V., Hare J. D. A rapid method for the isolation of rat liver plasma membranes using an aqueous two-phase polymer system. Biochim Biophys Acta. 1973 Jun 22;311(2):173–179. doi: 10.1016/0005-2736(73)90264-2. [DOI] [PubMed] [Google Scholar]
  22. Massague J., Guillette B. J., Czech M. P. Affinity labeling of multiplication stimulating activity receptors in membranes from rat and human tissues. J Biol Chem. 1981 Mar 10;256(5):2122–2125. [PubMed] [Google Scholar]
  23. Massagué J., Czech M. P. The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem. 1982 May 10;257(9):5038–5045. [PubMed] [Google Scholar]
  24. Megyesi K., Kahn C. R., Roth J., Neville D. M., Jr, Nissley S. P., Humbel R. E., Froesch E. R. The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. J Biol Chem. 1975 Dec 10;250(23):8990–8996. [PubMed] [Google Scholar]
  25. Pilch P. F., Czech M. P. The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cell and liver plasma membranes. J Biol Chem. 1980 Feb 25;255(4):1722–1731. [PubMed] [Google Scholar]
  26. Poretsky L., Grigorescu F., Seibel M., Moses A. C., Flier J. S. Distribution and characterization of insulin and insulin-like growth factor I receptors in normal human ovary. J Clin Endocrinol Metab. 1985 Oct;61(4):728–734. doi: 10.1210/jcem-61-4-728. [DOI] [PubMed] [Google Scholar]
  27. Rechler M. M., Zapf J., Nissley S. P., Froesch E. R., Moses A. C., Podskalny J. M., Schilling E. E., Humbel R. E. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology. 1980 Nov;107(5):1451–1459. doi: 10.1210/endo-107-5-1451. [DOI] [PubMed] [Google Scholar]
  28. Rinderknecht E., Humbel R. E. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem. 1978 Apr 25;253(8):2769–2776. [PubMed] [Google Scholar]
  29. Schwartz J., Foster C. M., Satin M. S. Growth hormone and insulin-like growth factors I and II produce distinct alterations in glucose metabolism in 3T3-F442A adipocytes. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8724–8728. doi: 10.1073/pnas.82.24.8724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sinha M. K., Miller J. D., Sperling M. A., Suchy F. J., Ganguli S. Possible dissociation between insulin binding and insulin action in isolated fetal rat hepatocytes. Diabetes. 1984 Sep;33(9):864–871. doi: 10.2337/diab.33.9.864. [DOI] [PubMed] [Google Scholar]
  31. Starzl T. E., Porter K. A., Francavilla J. A., Benichou J., Putnam C. W. A hundred years of the hepatotrophic controversy. Ciba Found Symp. 1977;(55):111–129. doi: 10.1002/9780470720363.ch6. [DOI] [PubMed] [Google Scholar]
  32. Unterman T. G., Phillips L. S. Circulating somatomedin activity during hepatic regeneration. Endocrinology. 1986 Jul;119(1):185–192. doi: 10.1210/endo-119-1-185. [DOI] [PubMed] [Google Scholar]
  33. Uthne K., Uthne T. Influence of liver resection and regeneration on somatomedin (sulphation factor) activity in sera from normal and hypophysectomized rats. Acta Endocrinol (Copenh) 1972 Oct;71(2):255–264. doi: 10.1530/acta.0.0710255. [DOI] [PubMed] [Google Scholar]
  34. Van Wyk J. J., Underwood L. E., Hintz R. L., Clemmons D. R., Voina S. J., Weaver R. P. The somatomedins: a family of insulinlike hormones under growth hormone control. Recent Prog Horm Res. 1974;30(0):259–318. [PubMed] [Google Scholar]
  35. Verspohl E. J., Roth R. A., Vigneri R., Goldfine I. D. Dual regulation of glycogen metabolism by insulin and insulin-like growth factors in human hepatoma cells (HEP-G2). Analysis with an anti-receptor monoclonal antibody. J Clin Invest. 1984 Oct;74(4):1436–1443. doi: 10.1172/JCI111555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Widmer U., Schmid C., Zapf J., Froesch E. R. Effects of insulin-like growth factors on chick embryo hepatocytes. Acta Endocrinol (Copenh) 1985 Feb;108(2):237–244. doi: 10.1530/acta.0.1080237. [DOI] [PubMed] [Google Scholar]
  37. Zapf J., Froesch E. R., Humbel R. E. The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. Curr Top Cell Regul. 1981;19:257–309. doi: 10.1016/b978-0-12-152819-5.50024-5. [DOI] [PubMed] [Google Scholar]
  38. Zapf J., Schoenle E., Froesch E. R. Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem. 1978 Jun 15;87(2):285–296. doi: 10.1111/j.1432-1033.1978.tb12377.x. [DOI] [PubMed] [Google Scholar]
  39. Zick Y., Sasaki N., Rees-Jones R. W., Grunberger G., Nissley S. P., Rechler M. M. Insulin-like growth factor-I (IGF-I) stimulates tyrosine kinase activity in purified receptors from a rat liver cell line. Biochem Biophys Res Commun. 1984 Feb 29;119(1):6–13. doi: 10.1016/0006-291x(84)91610-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES